C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 311/00 (2006.01) C07C 311/19 (2006.01) C07C 311/29 (2006.01) C07D 409/04 (2006.01)
Patent
CA 2285439
Compounds of formula (I) wherein R is hydroxy, hydrogen, alkenyl, alkynyl or aryl, and R1 is aryl or heteroaryl, are useful in the treatment and prophylaxis of conditions mediated by CD23 or TNF.
Composés représentés par la formule (I) dans laquelle R représente hydroxy, hydrogène, alkényle, alkynyle ou aryle et R1 représente aryle ou hétéroaryle, utiles pour le traitement ou la prophylaxie d'états provoqués par CD23 ou TNF.
Gowling Lafleur Henderson Llp
Smithkline Beecham P.l.c.
LandOfFree
Aryl- or heteroarylsulfonamide substituted hydroxamic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl- or heteroarylsulfonamide substituted hydroxamic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl- or heteroarylsulfonamide substituted hydroxamic acid... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2021784